239 related articles for article (PubMed ID: 31050579)
1. Fine-tuning AKT kinase activity through direct lysine methylation.
Guo J; Wei W
Cell Cycle; 2019 May; 18(9):917-922. PubMed ID: 31050579
[TBL] [Abstract][Full Text] [Related]
2. AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions.
Guo J; Dai X; Laurent B; Zheng N; Gan W; Zhang J; Guo A; Yuan M; Liu P; Asara JM; Toker A; Shi Y; Pandolfi PP; Wei W
Nat Cell Biol; 2019 Feb; 21(2):226-237. PubMed ID: 30692625
[TBL] [Abstract][Full Text] [Related]
3. Histone methylation modifiers in cellular signaling pathways.
Alam H; Gu B; Lee MG
Cell Mol Life Sci; 2015 Dec; 72(23):4577-92. PubMed ID: 26305020
[TBL] [Abstract][Full Text] [Related]
4. SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis.
Wang G; Long J; Gao Y; Zhang W; Han F; Xu C; Sun L; Yang SC; Lan J; Hou Z; Cai Z; Jin G; Hsu CC; Wang YH; Hu J; Chen TY; Li H; Lee MG; Lin HK
Nat Cell Biol; 2019 Feb; 21(2):214-225. PubMed ID: 30692626
[TBL] [Abstract][Full Text] [Related]
5. Aberrant JmjC domain-containing protein 8 (JMJD8) expression promotes activation of AKT and tumor epithelial-mesenchymal transition.
Su Y; Wang X; Guo Z; Wang J
Oncogene; 2020 Oct; 39(41):6451-6467. PubMed ID: 32879443
[TBL] [Abstract][Full Text] [Related]
6. Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential.
Strepkos D; Markouli M; Klonou A; Papavassiliou AG; Piperi C
Cancer Res; 2021 Feb; 81(3):525-534. PubMed ID: 33115801
[TBL] [Abstract][Full Text] [Related]
7. Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression.
Gao H; Yu Z; Bi D; Jiang L; Cui Y; Sun J; Ma R
Mol Cell Biochem; 2007 Nov; 305(1-2):35-44. PubMed ID: 17577629
[TBL] [Abstract][Full Text] [Related]
8. KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.
Li G; Kanagasabai T; Lu W; Zou MR; Zhang SM; Celada SI; Izban MG; Liu Q; Lu T; Ballard BR; Zhou X; Adunyah SE; Matusik RJ; Yan Q; Chen Z
Cancer Res; 2020 Nov; 80(21):4633-4643. PubMed ID: 32868382
[TBL] [Abstract][Full Text] [Related]
9. Targeting histone lysine methylation in cancer.
McGrath J; Trojer P
Pharmacol Ther; 2015 Jun; 150():1-22. PubMed ID: 25578037
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of PI3K/AKT in tumor-related epigenetic regulation.
Yang Q; Jiang W; Hou P
Semin Cancer Biol; 2019 Dec; 59():112-124. PubMed ID: 30951826
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.
Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T
PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683
[TBL] [Abstract][Full Text] [Related]
12. H3K4 Methylation Dependent and Independent Chromatin Regulation by
Lee KY; Chen Z; Jiang R; Meneghini MD
G3 (Bethesda); 2018 May; 8(5):1829-1839. PubMed ID: 29599176
[TBL] [Abstract][Full Text] [Related]
13. Lysine Methyltransferases Signaling: Histones are Just the Tip of the Iceberg.
Lukinović V; Casanova AG; Roth GS; Chuffart F; Reynoird N
Curr Protein Pept Sci; 2020; 21(7):655-674. PubMed ID: 31894745
[TBL] [Abstract][Full Text] [Related]
14. Histone lysine methyltransferase SETDB1 as a novel target for central nervous system diseases.
Markouli M; Strepkos D; Chlamydas S; Piperi C
Prog Neurobiol; 2021 May; 200():101968. PubMed ID: 33279625
[TBL] [Abstract][Full Text] [Related]
15. SETDB1, an H3K9-specific methyltransferase: An attractive epigenetic target to combat cancer.
Prashanth S; Radha Maniswami R; Rajajeyabalachandran G; Jegatheesan SK
Drug Discov Today; 2024 May; 29(5):103982. PubMed ID: 38614159
[TBL] [Abstract][Full Text] [Related]
16. miR24-2 accelerates progression of liver cancer cells by activating Pim1 through tri-methylation of Histone H3 on the ninth lysine.
Yang Y; Song S; Meng Q; Wang L; Li X; Xie S; Chen Y; Jiang X; Wang C; Lu Y; Xin X; Pu H; Gui X; Li T; Xu J; Li J; Jia S; Lu D
J Cell Mol Med; 2020 Mar; 24(5):2772-2790. PubMed ID: 32030886
[TBL] [Abstract][Full Text] [Related]
17. PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer.
Spangle JM; Dreijerink KM; Groner AC; Cheng H; Ohlson CE; Reyes J; Lin CY; Bradner J; Zhao JJ; Roberts TM; Brown M
Cell Rep; 2016 Jun; 15(12):2692-704. PubMed ID: 27292631
[TBL] [Abstract][Full Text] [Related]
18. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3.
Cha TL; Zhou BP; Xia W; Wu Y; Yang CC; Chen CT; Ping B; Otte AP; Hung MC
Science; 2005 Oct; 310(5746):306-10. PubMed ID: 16224021
[TBL] [Abstract][Full Text] [Related]
19. The functions of SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) in biological process and disease.
Luo H; Wu X; Zhu XH; Yi X; Du D; Jiang DS
Epigenetics Chromatin; 2023 Dec; 16(1):47. PubMed ID: 38057834
[TBL] [Abstract][Full Text] [Related]
20. SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1.
Yoshioka Y; Suzuki T; Matsuo Y; Nakakido M; Tsurita G; Simone C; Watanabe T; Dohmae N; Nakamura Y; Hamamoto R
Oncotarget; 2016 Nov; 7(46):75023-75037. PubMed ID: 27626683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
